London, UK, 10 February 2022: PharmaVentures today announced it has moved its operational headquarters from Oxford to London as part of its continued strategic expansion. The company will retain its remaining operational and administrative functions at its new registered office in Oxford.
Dr Fintan Walton, Chief Executive and Founder of PharmaVentures said: “As a leading global transaction advisory firm, it makes sense that PharmaVentures moves its functional operations to one of world’s leading financial cities. We wanted a location that reflects PharmaVentures’ forward-thinking culture and enterprise. So, in the end London was the obvious choice.”
The new London Headquarters is close to Paddington Station, serving both Oxford and London’s Heathrow Airport, and making it extremely convenient for its global clients travelling to London. Located in the West End and in the newly developed and dynamic city campus called Paddington Central, the offices are just a short walk from London’s famous and quaint Little Venice where the Grand Union Canal meets Regent’s Canal.
The new London address is: One Kingdom Street, Fourth Floor, Paddington, London W2 6BD, United Kingdom
The new Oxford and registered address is: Oxford House, Oxford Business Park South, Oxford OX4 2JY, United Kingdom.
Senior Marketing Manager